Cargando…
Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity
Scaffolding the calcium/calmodulin-dependent phosphatase 2B (PP2B, calcineurin) focuses and insulates termination of local second messenger responses. Conformational flexibility in regions of intrinsic disorder within A-kinase anchoring protein 79 (AKAP79) delineates PP2B access to phosphoproteins....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653234/ https://www.ncbi.nlm.nih.gov/pubmed/28967377 http://dx.doi.org/10.7554/eLife.30872 |
_version_ | 1783273204141260800 |
---|---|
author | Nygren, Patrick J Mehta, Sohum Schweppe, Devin K Langeberg, Lorene K Whiting, Jennifer L Weisbrod, Chad R Bruce, James E Zhang, Jin Veesler, David Scott, John D |
author_facet | Nygren, Patrick J Mehta, Sohum Schweppe, Devin K Langeberg, Lorene K Whiting, Jennifer L Weisbrod, Chad R Bruce, James E Zhang, Jin Veesler, David Scott, John D |
author_sort | Nygren, Patrick J |
collection | PubMed |
description | Scaffolding the calcium/calmodulin-dependent phosphatase 2B (PP2B, calcineurin) focuses and insulates termination of local second messenger responses. Conformational flexibility in regions of intrinsic disorder within A-kinase anchoring protein 79 (AKAP79) delineates PP2B access to phosphoproteins. Structural analysis by negative-stain electron microscopy (EM) reveals an ensemble of dormant AKAP79-PP2B configurations varying in particle length from 160 to 240 Å. A short-linear interaction motif between residues 337–343 of AKAP79 is the sole PP2B-anchoring determinant sustaining these diverse topologies. Activation with Ca2(+)/calmodulin engages additional interactive surfaces and condenses these conformational variants into a uniform population with mean length 178 ± 17 Å. This includes a Leu-Lys-Ile-Pro sequence (residues 125–128 of AKAP79) that occupies a binding pocket on PP2B utilized by the immunosuppressive drug cyclosporin. Live-cell imaging with fluorescent activity-sensors infers that this region fine-tunes calcium responsiveness and drug sensitivity of the anchored phosphatase. |
format | Online Article Text |
id | pubmed-5653234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-56532342017-10-25 Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity Nygren, Patrick J Mehta, Sohum Schweppe, Devin K Langeberg, Lorene K Whiting, Jennifer L Weisbrod, Chad R Bruce, James E Zhang, Jin Veesler, David Scott, John D eLife Biochemistry and Chemical Biology Scaffolding the calcium/calmodulin-dependent phosphatase 2B (PP2B, calcineurin) focuses and insulates termination of local second messenger responses. Conformational flexibility in regions of intrinsic disorder within A-kinase anchoring protein 79 (AKAP79) delineates PP2B access to phosphoproteins. Structural analysis by negative-stain electron microscopy (EM) reveals an ensemble of dormant AKAP79-PP2B configurations varying in particle length from 160 to 240 Å. A short-linear interaction motif between residues 337–343 of AKAP79 is the sole PP2B-anchoring determinant sustaining these diverse topologies. Activation with Ca2(+)/calmodulin engages additional interactive surfaces and condenses these conformational variants into a uniform population with mean length 178 ± 17 Å. This includes a Leu-Lys-Ile-Pro sequence (residues 125–128 of AKAP79) that occupies a binding pocket on PP2B utilized by the immunosuppressive drug cyclosporin. Live-cell imaging with fluorescent activity-sensors infers that this region fine-tunes calcium responsiveness and drug sensitivity of the anchored phosphatase. eLife Sciences Publications, Ltd 2017-10-02 /pmc/articles/PMC5653234/ /pubmed/28967377 http://dx.doi.org/10.7554/eLife.30872 Text en © 2017, Nygren et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Biochemistry and Chemical Biology Nygren, Patrick J Mehta, Sohum Schweppe, Devin K Langeberg, Lorene K Whiting, Jennifer L Weisbrod, Chad R Bruce, James E Zhang, Jin Veesler, David Scott, John D Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity |
title | Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity |
title_full | Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity |
title_fullStr | Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity |
title_full_unstemmed | Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity |
title_short | Intrinsic disorder within AKAP79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity |
title_sort | intrinsic disorder within akap79 fine-tunes anchored phosphatase activity toward substrates and drug sensitivity |
topic | Biochemistry and Chemical Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653234/ https://www.ncbi.nlm.nih.gov/pubmed/28967377 http://dx.doi.org/10.7554/eLife.30872 |
work_keys_str_mv | AT nygrenpatrickj intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT mehtasohum intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT schweppedevink intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT langeberglorenek intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT whitingjenniferl intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT weisbrodchadr intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT brucejamese intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT zhangjin intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT veeslerdavid intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity AT scottjohnd intrinsicdisorderwithinakap79finetunesanchoredphosphataseactivitytowardsubstratesanddrugsensitivity |